Patients on US-funded HIV drugs died within months.

Camps here relied on PEPFAR for nearly all antiretroviral supply; 2025 cuts triggered viral rebound on a clinical delay.

The deaths register as HIV, not policy, since PEPFAR’s patient counts stopped publishing when the funding did.

Sources: New Lines Magazine